Printer Friendly

SOMANETICS CORPORATION ANNOUNCES REDEMPTION OF CLASS A, CLASS B WARRANTS

SOMANETICS CORPORATION ANNOUNCES REDEMPTION OF CLASS A, CLASS B WARRANTS
 TROY, Mich., March 30 /PRNewswire/ -- Somanetics Corporation (NASDAQ: SMTS) announced that it is exercising its right under its Warrant Agreement dated March 20, 1991, to redeem its Class A Warrants which have not been validly exercised on or before May 5, 1992, at 5 p.m. (New York City time), and to redeem its Class B Warrants which have not been validly exercised on or before Sept. 29, 1992, at 5 p.m. (New York City time).
 Each Class A Warrant entitles the registered holder to purchase one Somanetics Corporation Common Share and to receive one Class B Warrant at an exercise price of $3 per share. Each Class B Warrant entitles the registered holder to purchase one Somanetics Corporation Common Share at an exercise price of $4 per share. Pursuant to its Warrant Agreement, the company has the right to redeem the Class A and Class B Warrants because the average closing bid price of the company's Common Shares, as reported by NASDAQ, has exceeded $4.20 per share and $5.10 per share for the 30 consecutive business-day period ended March 20, 1992. The 30 consecutive business-day average closing bid price of the Common Shares for the period ended March 20, 1992, was $5.42.
 The date fixed for redemption of the Class A Warrants is May 6, 1992. The date fixed for redemption of the Class B Warrants is Sept. 30, 1992. Any Class A and Class B Warrants which have not been exercised prior to their respective redemption dates will no longer be exercisable to purchase Common Shares (and receive Class B Warrants for the Class A Warrant holders). Holders of the Class A and Class B Warrants will have no further rights beyond the respective Warrant redemption dates, except to receive, upon surrender of the Warrant certificates evidencing redeemed Warrants, payment of the redemption price of $.05 for each Class A and Class B Warrant outstanding and not already exercised as of their respective redemption dates.
 Through March 20, 1992, the company received $2,660,428 in proceeds from the exercise of 852,116 Class A Warrants and 26,020 Class B Warrants and issued 878,136 Common Shares and 852,116 Class B Warrants as a result of such exercises.
 The company expects to use proceeds from the Warrant exercises to continue to expand its sales and marketing activities to market the Cerebral Oximeter, domestically through its own employees and independent distributors and internationally through independent distributors, to hospitals for use in the operating room, recovery room, intensive care unit and emergency room. In addition, the company intends to identify other applications of its INVOS(R) technology. Initially, the company will focus its efforts on developing product extensions of the Cerebral Oximeter for use on children and newborns.
 Notice of redemption of Class A and Class B Warrants will be delivered to registered Warrant holders. Warrant holders seeking information about the method of exercise of their Warrants or redemption of their Warrants can call the Information Agent, Shareholder Communications Corporation, at 1-800-678-9601 or 212-809-3600, or the Somanetics Investor Relations Department at 313-689-3050.
 Somanetics Corporation, headquartered in Troy, develops, manufactures and markets computer-based medical diagnostic and monitoring equipment using In Vivo Optical Spectroscopy (INVOS) technology. The company has developed the INVOS 3100 Cerebral Oximeter and the related disposable SomaSensor(TM) which uses INVOS technology to measure, continuously, directly and noninvasively, oxygen saturation of the blood in portions of an adult's brain. The Cerebral Oximeter is intended for use in the operating room, recovery room, emergency room and intensive care units.
 The company's Units, Common Shares and Class A and Class B Warrants have been traded in the over-the-counter market and have been quoted in the NASDAQ system under the symbols SMTSU, SMTS, SMTSW and SMTSZ, respectively.
 -0- 3/30/92
 /CONTACT: Mary Ann Robb of Somanetics Corporation, 313-689-3996/
 (SMTS) CO: Somanetics Corporation ST: Michigan IN: MTC SU:


SM-JG -- DE014 -- 2895 03/30/92 12:31 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 30, 1992
Words:671
Previous Article:/C O R R E C T I O N -- SANTA FE ENERGY RESOURCES/
Next Article:SNO COUNTRY REPORTS OFFICIAL SKI REPORT FOR MARCH 30, 1992
Topics:


Related Articles
SOMANETICS CORPORATION SECURITIES WILL TRADE IN NASDAQ NATIONAL MARKET
SOMANETICS ANNOUNCES EXTENDED REDEMPTION PERIOD FOR CLASS B WARRANTS AND REVISED SHIPPING SCHEDULE
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO DEC. 29, 1993
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO AUGUST 4, 1995
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO NOVEMBER 9, 1995
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO MARCH 20, 1996
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO SEPTEMBER 26, 1996
Somanetics Announces Extension of Redemption Date for Class B Warrants to November 14, 1996
Somanetics Proceeds with Redemption of Class B Warrants
Somanetics Announces Completion of Stock Offering

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters